These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18435811)

  • 61. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
    Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
    Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.
    Mylona E; Giannopoulou I; Diamantopoulou K; Bakarakos P; Nomikos A; Zervas A; Nakopoulou L
    Eur J Surg Oncol; 2009 Feb; 35(2):197-201. PubMed ID: 18513919
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [PTa bladder tumours: prognostic factors of recurrence and progression].
    Martinache G; Zerbib M; Descazeaud A; Debré B; Peyromaure M
    Prog Urol; 2008 Jan; 18(1):35-40. PubMed ID: 18342154
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic markers in muscle invasive bladder cancer.
    Tiguert R; Lessard A; So A; Fradet Y
    World J Urol; 2002 Aug; 20(3):190-5. PubMed ID: 12196903
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stage of urinary bladder cancer at first presentation.
    Al-Bazzaz PH
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):628-31. PubMed ID: 19587505
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
    Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
    Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bladder cancer grading using the four-tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classifications.
    Jahnson S; Jancke G; Olsson H; Aljabery F
    BJU Int; 2023 Dec; 132(6):656-663. PubMed ID: 37409847
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
    Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M
    Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
    Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K
    Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma.
    Babjuk M; Soukup V; Pesl M; Kostírová M; Drncová E; Smolová H; Szakacsová M; Getzenberg R; Pavlík I; Dvorácek J
    Urology; 2008 Apr; 71(4):718-22. PubMed ID: 18387400
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
    Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
    BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer.
    Piet AH; Hulshof MC; Pieters BR; Pos FJ; de Reijke TM; Koning CC
    Strahlenther Onkol; 2008 Jun; 184(6):313-8. PubMed ID: 18535807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.
    Arduino PG; Carrozzo M; Chiecchio A; Broccoletti R; Tirone F; Borra E; Bertolusso G; Gandolfo S
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1570-9. PubMed ID: 18634942
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
    Pfitzenmaier J; Pahernik S; Tremmel T; Haferkamp A; Buse S; Hohenfellner M
    BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.
    Otto W; Denzinger S; Fritsche HM; Burger M; Wieland WF; Hofstädter F; Hartmann A; Bertz S
    BJU Int; 2011 Feb; 107(3):404-8. PubMed ID: 20707791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.